NCT07150520View on ClinicalTrials.gov

VR-Based Optokinetic Stimulation in Multiple Sclerosis

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Multiple Sclerosis
Interventions
DEVICE

Virtual Reality-Based Optokinetic Stimulation (OKS)

A 10-minute session of virtual reality-based optokinetic stimulation (OKS) using the Oculus Quest 2 system. The stimulation speed is set at 40°/s and the direction is determined according to Fukuda test results. Postural sway and motion sickness will be assessed before and after the intervention.

All Listed Sponsors
collaborator

Hacettepe University

OTHER

lead

Avrasya University

OTHER